MnO/sub 2/-Co/sub 3/O/sub 4/-Fe/sub 2/O/sub 3/-Bi/sub 2/O/sub 3/
In vitro and in vivo targeting imaging of pancreatic cancer using a Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanoprobe modified with anti-mesothelin antibody
... nanoprobe Fe 3 O 4 @SiO 2 modified with anti-mesothelin antibody (A-MFS) was prepared to target cells and tumor tissues highly expressing mesothelin in vitro (human pancreatic cancer ...
13
Immobilized transferrin Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanoparticle with high doxorubicin loading for dual-targeted tumor drug delivery
... DMP was suspended in 10 mL phosphate-buffered saline (PBS) solution, and incubated with 5 mg EDC and 5 mg NHS for 30 minutes at room temperature. Then, the products were separated using magnetic separation and ...
9
Biological responses to core–shell-structured Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>-NH<sub>2</sub> nanoparticles in rats by a nuclear magnetic resonance-based metabonomic strategy
... All univariate statistical tests were two-sided, and sig- nificance was set at P,0.05. Multivariate statistical analysis can take internal relationships and mutual influence among variables into account; therefore, the ...
16
Polyetherimide-grafted Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanoparticles as theranostic agents for simultaneous VEGF siRNA delivery and magnetic resonance cell imaging
... of Fe 3 O 4 @SiO 2 ...the Fe 3 O 4 @SiO 2 and Fe 3 O 4 @SiO 2 /PEI ...the Fe 3 O 4 @SiO ...
13
Vancomycin-modified Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>@Ag microflowers as effective antimicrobial agents
... and Fe 3 O 4 @SiO 2 microsphere-treated solutions did not inhibit the bacterial ...The Fe 3 O 4 @ SiO 2 –Ag seed showed higher antibacterial ...
18
Biosafety evaluation of Janus Fe<sub>3</sub>O<sub>4</sub>-TiO<sub>2</sub> nanoparticles in Sprague Dawley rats after intravenous injection
... molecular weights. Immunoblots for expression of p38, p-p38, JNK, p-JNK, HO-1, ERK, c-Jun, cleaved caspase 3, Bcl2, Bax, P50, p53, Nrf2, Akt, and GAPDH were detected. All antibodies for Western blot in this study ...
15
Toxicity evaluation of Gd<sub>2</sub>O<sub>3</sub>@SiO<sub>2</sub> nanoparticles prepared by laser ablation in liquid as MRI contrast agents in vivo
... 5% CO 2 ...another 4 hours of incubation, then removed the culture medium and replaced with 100 µ L DMSO (dimethyl sulfoxide), followed by 10 minutes of ...
11
The changes of T lymphocytes and cytokines in ICR mice fed with Fe<sub>3</sub>O<sub>4</sub> magnetic nanoparticles
... (Fe 3 O 4 ) nanoparticles with appropriate surface modification, which have been widely used experimentally for numerous in vivo applications, such as magnetic resonance imaging, tissue ...
6
Biocompatibility of magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles and their cytotoxic effect on MCF-7 cells
... the Fe 3 O 4 nanoparticles were approximately spherical, with diameters of about ...The O-to-Fe ratio of the Fe 3 O 4 was determined by scanning ...
10
Effect of interaction of magnetic nanoparticles of Fe<sub>3</sub>O<sub>4</sub> and artesunate on apoptosis of K562 cells
... purchased: 3-(4, 5- dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT) (Ameresco, Solon, OH); Z-VAD-FMK (Beyotime Biotechnology); RPMI 1640 medium and fetal calf serum (GIBCO, USA); ...
8
Multifunctional magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles combined with chemotherapy and hyperthermia to overcome multidrug resistance
... daunorubicin, Fe 3 O 4 -MNP, and Fe 3 O 4 -MNP coloaded with daunorubicin and 5-bromotetrandrine (Fe 3 O 4 -MNP-DNR-5-BrTet), with ...
9
The effect of magnetic nanoparticles of Fe<sub>3</sub>O<sub>4</sub> on immune function in normal ICR mice
... group) Fe 3 O 4 -MNPs, were dissolved in normal saline and intravenously (iv) injected into mice ...at 4 ° C to separate plasma and blood ...
7
Co-encapsulation of magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles and doxorubicin into biodegradable PLGA nanocarriers for intratumoral drug delivery
... of Fe 3 O 4 particles inside tumor cells was found to increase when a simple external magnetic field was applied, indicating the concentration of DOX in the tumor was ...
12
Synthesis of composite magnetic nanoparticles Fe<sub>3</sub>O<sub>4</sub> with alendronate for osteoporosis treatment
... (Sigma-Aldrich Co.), ascorbic acid (C 6 H 8 O 6 ; Sigma-Aldrich ...(NaHCO 3 ; Sigma-Aldrich ...[KH 2 PO 4 ; Sigma-Aldrich ...Sigma-Aldrich Co.], sodium phosphate dibasic [Na ...
12
Preparation of Fe<sub>3</sub>O<sub>4</sub> magnetic nanoparticles coated with gallic acid for drug delivery
... Transmission electron microscopy of the magnetic iron oxide nanoparticles and iron oxide nanoparticles coated with chitosan and gallic acid was performed to determine the shape, size, and uniformity of the particles ...
12
The effects of magnetite (Fe<sub>3</sub>O<sub>4</sub>) nanoparticles on electroporation-induced inward currents in pituitary tumor (GH<sub>3</sub>) cells and in RAW 264.7 macrophages
... of Fe 3 O 4 NPs on I MEP , we studied whether the nanoparticles could alter the I MEP measured at the different levels of membrane potentials in these ...Figure 2 shows the I–V ...
10
Biocompatibility of Fe<sub>3</sub>O<sub>4</sub>/DNR magnetic nanoparticles in the treatment of hematologic malignancies
... Reagent Co, Ltd (Shanghai, ...Products Co Ltd (Shanghai, ...Medicine Co Ltd., Lianyungang, China) methanol (Sinopharm Chemical Reagent Co Ltd, Shanghai, China), Giemsa staining solution ...
6
Fe<sub>3</sub>O<sub>4</sub>/Au magnetic nanoparticle amplification strategies for ultrasensitive electrochemical immunoassay of alfa-fetoprotein
... the Fe 3 O 4 /Au nanocarrier, the ratio of HRP and Ab 2 is the most important factor in the response ...HRP/Ab 2 , and the maxi- mum response is achieved at a ratio of ...HRP/Ab ...
11
In vitro toxicity of Fe<sub>m</sub>O<sub>n</sub>, Fe<sub>m</sub>O<sub>n</sub>-SiO<sub>2</sub> composite, and SiO<sub>2</sub>-Fe<sub>m</sub>O<sub>n</sub> core-shell magnetic nanoparticles
... uncoated, Fe m O n -SiO 2 composite flake-like, and SiO 2 -Fe m O n core-shell IONPs on cell viability, function, and mor- phology were tested 48 h postincubation in human ...
11
Preparation and in vitro evaluation of doxorubicin-loaded Fe<sub>3</sub>O<sub>4</sub> magnetic nanoparticles modified with biocompatible copolymers
... minor modifications. An aqueous solution of doxorubicin 5 mg/5 mL was emulsified in 10 mL dichloromethane, in which 120 mg of the copolymer and 4 mg magnetic nanopar- ticles had been dissolved, using a probe ...
16